chr9-130354932-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001291815.2(HMCN2):c.5034C>T(p.Asp1678Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00335 in 1,303,718 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0026 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0035 ( 16 hom. )
Consequence
HMCN2
NM_001291815.2 synonymous
NM_001291815.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.51
Genes affected
HMCN2 (HGNC:21293): (hemicentin 2) Predicted to enable calcium ion binding activity. Predicted to be an extracellular matrix structural constituent. Predicted to be involved in cell adhesion. Located in collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 9-130354932-C-T is Benign according to our data. Variant chr9-130354932-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2659590.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-4.51 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMCN2 | NM_001291815.2 | c.5034C>T | p.Asp1678Asp | synonymous_variant | 32/98 | ENST00000683500.2 | NP_001278744.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMCN2 | ENST00000683500.2 | c.5034C>T | p.Asp1678Asp | synonymous_variant | 32/98 | NM_001291815.2 | ENSP00000508292.2 | |||
HMCN2 | ENST00000624552.4 | c.5034C>T | p.Asp1678Asp | synonymous_variant | 32/98 | 5 | ENSP00000485357.2 |
Frequencies
GnomAD3 genomes AF: 0.00260 AC: 396AN: 152172Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
396
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00235 AC: 345AN: 146594Hom.: 1 AF XY: 0.00243 AC XY: 192AN XY: 79074
GnomAD3 exomes
AF:
AC:
345
AN:
146594
Hom.:
AF XY:
AC XY:
192
AN XY:
79074
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00345 AC: 3977AN: 1151428Hom.: 16 Cov.: 31 AF XY: 0.00344 AC XY: 1943AN XY: 564592
GnomAD4 exome
AF:
AC:
3977
AN:
1151428
Hom.:
Cov.:
31
AF XY:
AC XY:
1943
AN XY:
564592
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00260 AC: 396AN: 152290Hom.: 2 Cov.: 33 AF XY: 0.00235 AC XY: 175AN XY: 74462
GnomAD4 genome
AF:
AC:
396
AN:
152290
Hom.:
Cov.:
33
AF XY:
AC XY:
175
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | HMCN2: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at